|
|
||||||||

* Department of Animal and Poultry Science, University of Guelph, Guelph, ON, Canada N1G 2W1
Division of Nutritional Sciences, Cornell University, Ithaca, NY 14853
1 Corresponding author: bmcbride{at}uoguelph.ca
| ABSTRACT |
|---|
|
|
|---|
Key Words: acetyl CoA carboxylase fatty acid fatty acid synthase metabolic control analysis
| INTRODUCTION |
|---|
|
|
|---|
Manipulations of milk fat composition inevitably alter the rates of some of the underlying biological processes that support de novo synthesis of FA; it is the regulation of processes such as substrate transport and enzyme activity or abundance that determines the final FA composition of milk. Fatty acids expressed in bovine milk are either synthesized de novo in the mammary glands from acetate and BHBA, or are absorbed from the bloodstream (Palmquist et al., 1993). Approximately half of palmitic acid and all of the longer chain length FA, are absorbed from blood, whereas short- and medium-chain FA and half of palmitic acid are synthesized within mammary epithelial cells.
De novo FA synthesis requires the coordinated functioning of numerous biological systems from the delivery of substrates to the mammary epithelial cells to the completion of the newly synthesized FA, to, finally, the formation of milk fat globules. Acetyl-CoA carboxylase (ACC; EC 6.4.1.2) is commonly described in the literature as the rate-limiting enzyme in the synthesis of de novo FA (Molenaar et al., 2003), although Volpe and Vagelos (1976) noted that the evidence from in vivo studies to support this position was not conclusive. Hardie (1989) suggested that the degree to which ACC could be considered rate limiting would depend on tissue type and the precursors available and noted that rate limiting would be more correctly defined in terms of control strength, a forerunner to the terminology of control coefficient, used in metabolic control analysis (MCA). Acetyl-CoA carboxylase is the enzyme responsible for the formation of malonyl-CoA, the intermediary substrate necessary for chain elongation by the multifunctional enzyme FA synthase (FAS; EC 2.3.1.85; Smith, 1994).
Metabolic control analysis has been reviewed by Fell (1992, 1997). The MCA approach assumes a sharing or distribution of control among the individual elements of a biological pathway. Interactions within metabolic pathways, either through shared substrates or intermediates or from higher levels of biochemical organization, make pathways resistant to the redirection of flux from external modulation. The alternative concept of single control points, often described as rate-limiting or pace-maker steps, is replaced by the determination of control coefficients that represent the proportion of control exerted by each individual step. Plant biologists have already examined FA synthesis using the MCA approach (Page et al., 1994), and reported a flux control coefficient of 0.54, or 54%, for ACC. A 50-fold overexpression of the gene for ACC in Escherichia coli resulted in only a 6-fold increase in FA synthesis (Davis et al., 2000), which indicates that a degree of control must be exerted by pathway constituents downstream from ACC. A complete examination of control coefficients for all steps of de novo FA synthesis in the mammary glands would require numerous experiments. The objective of this experiment was to determine the control coefficients for ACC and FAS in a defined in vitro system to test the hypothesis that ACC is rate-limiting for FA synthesis, and therefore has a control coefficient equal to unity.
| MATERIALS AND METHODS |
|---|
|
|
|---|
In Vitro Incubations
Incubations were conducted based on the methods of Wright et al. (2002), and chemicals were purchased from Sigma-Aldrich (Oakville, ON, Canada) except where noted. Concentrations in the final incubation solution (3 mL) were 80 mM Tris-HCl, 0.8 mM MnCl2, 20 mM sodium bicarbonate, 0.05 mM coenzyme A, 1.7 mM ATP, 10 mM sodium citrate, 0.5 mM glucose 6-P, 1.7 mM sodium acetate, 4.2 mM reduced glutathione, 0.05 mM NADPH, 20 mg/mL FA-free BSA, 5.0 µL of mammalian protease inhibitor (P-8340), and 1 to 5 mg of homogenate protein. Vernon and Taylor (1986) noted that pyruvate carboxylase (EC 2.7.1.40) activity can contribute to assays intended to determine ACC activity based on 14C incorporation from H14CO3 into acid-stable products when using homogenate preparations. Pyruvate, the substrate for pyruvate carboxylase activity was removed from the present assay by desalting the supernatant preparation using a Nanosep centrifugal concentrator with a 10-kDa molecular weight cut-off filter (Northborough, MA) according to the manufacturers directions.
The assay for ACC activity was adapted from the methods of Ingle et al. (1973) and Vernon and Taylor (1986) in which the incorporation of 14C from H14CO3 into acid-stable products (e.g., malonyl-CoA) was measured. Approximately 1 µCi of H14CO3 (sodium salt) was added to the 3-mL incubation solutions in 20-mL glass scintillation vials, and sealed with rubber stoppers containing a polypropylene center well (Kimble Kontes, Mandel Scientific Co., Guelph, ON). After 10 min in a shaking water bath at 37°C, reactions were stopped by injecting 200 µL of 6 N HCl through the rubber stopper into the incubation solution. Two hundred microliters of tissue solubilizer (Amersham Canada Ltd., Oakville, ON, Canada) was placed in the center well before the incubations started to trap radioactive CO2 released after the addition of HCl. Scintillation vials were removed from the water bath and transferred to a 60°C dry bath in a fume hood. Rubber stoppers and the center wells were removed after 1 h and crushed dry ice was added to the scintillation vials to eliminate unreacted H14CO3 (Ingle et al., 1973). A 1-mL sample of the incubation solution from the scintillation vial was transferred to a clean scintillation vial and 10-mL of universal scintillation cocktail (Formula 989, NEN Research, Boston, MA) was added. Scintillation spectroscopy was conducted in a Beckman LS6000SC scintillation counter (Fullerton, CA). Blank incubations were conducted without protein or substrate, and approximately 1 µCi of H14CO3 was counted for specific activity calculations. Homogenate protein content was estimated using the bicinchoninic reaction with BSA as the standard, according to kit instructions (Pierce, Rockford, IL).
Assays of FA synthesis rate were conducted according to Wright et al. (2002) for 60 min using the same incubation conditions as above, except that no H14CO3 was included in the incubations. Instead, 1 µCi of [1-14C] acetic acid (sodium salt) was included as the label, and synthesized FA were extracted and counted by liquid scintillation. Net acetate incorporation was calculated by subtracting blank values from incubation results, and dividing by the specific activity of [1-14C] acetic acid.
Inhibition of enzyme activity for calculation of control coefficients was accomplished with avidin for ACC and pyridoxal 5-phosphate for FAS (Wakil et al., 1983). From 0 to 10 µM avidin was added to incubation solutions described above after a brief activation period for the homogenate protein in the incubation solution.
Individual FA synthesized de novo in the homogenate were determined by analyzing incubations that used a stable isotope of acetate instead of the radioisotope. A preliminary set of incubations indicated that a 1:50 ratio of [1, 2-13C] acetate (Cambridge Isotope Laboratories Inc., Andover, MA) with natural abundance acetate was sufficient to measure the incorporation of [1, 2-13C] acetate into FA. Stable isotope incubations containing no inhibitors, 1 and 2 µM avidin, or pyridoxal 5-phosphate were stopped by immersing in a salt and ice mixture, and immediately frozen at 20°C. Fatty acids were extracted from the incubations containing stable isotope by using 2 extractions of 1:2 chloroform:methanol (vol/vol), and transmethylated in the presence of boron trichloride. The purified FA methyl esters were disolved in hexane (Lipid Analytic Laboratories, Guelph, ON) before transport to Cornell University (Ithaca, NY). Methyl esters labeled with 13C acetate were analyzed by gas chromatography-combustion isotope ratio mass spectrometry (GCC-IRMS) according to the methods described by Su and Brenna (1998) and Huang et al. (2000).
Data Analysis
Metabolic control analysis was conducted using only the results obtained from the assays that measured the incorporation of radiolabeled substrate into total FA. Flux control coefficients (CJ) for each enzyme (Ei) representing the degree to which total FA synthesis was affected by either ACC or FAS inhibition were calculated according to Derr (1985, 1986):
![]() | [1] |
where J is the uninhibited rate of FA synthesis, (
J/
I)I=0 is the initial slope of the decline in FA synthesis at zero inhibition, Imax is maximal inhibition value, S is substrate concentration, and Ks is the substrate constant.
The summation theorem (Fell, 1992) was used to calculate the remaining control coefficient as:
![]() | [2] |
The value of (
J/
I)I=0 was obtained by first estimating inhibition constant Ki from fits of the equation Inhibition = I/[I+Ki x (1+S/KS)] to plots of degree of inhibition of FA synthesis vs. inhibitor concentration (I) using the nonlinear regression procedure of SAS (SAS Institute, 2000). The value of Ks was estimated from plots of ACC activity vs. acetate concentration utilizing the software Leonora (version 1.0), which was designed for analysis of enzyme kinetic data (Cornish-Bowden, 1995); IMAX was determined by titration with inhibitor until less than 5% of uninhibited assay activity was detected.
Control coefficient results were tested for a difference from unity (CJ = 1.0) by Students t-test using SAS (SAS, Institute, 2000). Data for the incorporation of the stable isotope of acetate into FA were analyzed as a completely randomized design using Proc GLM of SAS (SAS, Institute, 2000). Differences in the profiles of FA synthesized between treatments and control were detected using the PDIFF option after a significant F-statistic. Significance was taken as P < 0.05.
| RESULTS AND DISCUSSION |
|---|
|
|
|---|
|
In vitro mammary preparations have previously been used to investigate FA synthesis. DeKay et al. (1976), using a cytosolic preparation of bovine mammary tissue, reported incorporation of labeled acetate into C4:0, C6:0, and C8:0 of 15, 10, and 8%, respectively, and equal incorporation into C14:0 and C16:0 pools. The similar incorporation into C14:0 and C16:0 was primarily a result of reduced incorporation into C16:0 compared with expectations from in vivo measures. Conditions used herein for the GCC-IRMS did not permit the separation of short-chain FA. Hansen and Knudsen (1987) reported the profile of de novo FA synthesized by bovine mammary epithelial cells that incorporated [1-14C] acetate into several lipid classes including free FA and triacylglycerols. As in the present experiments, the greatest incorporation of acetate was into C14:0. These data indicate that for in vitro models of bovine mammary FA synthesis, there is a change in the FA profile produced compared with in vivo FA synthesis, likely due to the differences in the intracellular associations between FA synthesis and triacylglycerol synthesis machinery. The similarity in FA profiles between treatments confirms that MCA can be applied to the ACC and FAS synthesis fluxes by the inhibitors used herein. The MCA analysis accounted for all FA chain lengths synthesized by using the data obtained from the incorporation and detection of radiolabeled substrate into total FA.
Flux Control Coefficients
Inhibition of acetate incorporation into FA by avidin is shown in Figure 2
. The data from Figure 2
were used to calculate the initial slope of the normalized flux as inhibitor concentration approached zero. The value of Ks obtained from the radiolabeled bicarbonate incubations was 3.51 x 106, and the maximal inhibitor concentration was 8.7 x 103 mM. The initial slope of the avidin inhibition curve as the inhibitor concentration approached the limit of zero was calculated as 0.15 ± 0.04.
|
Data from the experiments using pyridoxal 5-phosphate to inhibit FAS indicated that the control coefficient for FAS was 0.24; and, according to the summation theorem (equation 2), the control coefficient for ACC was 0.76. However, the drawback to the use of an inhibitor for the second reaction in a pathway is that, whereas in the first reaction, substrate concentration is experimentally set, that is not the case for downstream reactions. The reduced activity of FAS could increase the concentration of the intermediate substrate, malonyl-CoA, because it would be utilized more slowly by the inhibited FAS, and cause underestimation of the control coefficient. Therefore, although there is some consistency to the results of the 2 approaches for calculating a control coefficient, the results of the avidin inhibition correctly satisfy the requirements of MCA that concentrations remain constant. It should be noted that, in either case, the control coefficient calculated for ACC was significantly different from unity.
In general, the use of subcellular preparations is less desirable as an experimental model for MCA than experiments that use whole cells or organelles such as mitochondria (Fell, 1997). The cell membrane disruption that occurs when homogenates are prepared eliminates potential control from transporters. Torres et al. (1986) studied glycolytic activity in rat liver homogenates using an enzyme addition technique to increase pathway flux. Despite the constraints of their homogenate model (such as a more dilute medium than the cytosol, and truncation of the pathway), their findings were consistent with subsequent investigations using whole-cell models (Fell, 1997). Use of homogenate models provides valuable insight into in vivo situations.
Inhibition of ACC by avidin was studied in avian liver (Wakil et al., 1958). In their experiment, incremental reductions in FA synthesis were achieved with corresponding increments of avidin. The lowest reduction in FA synthesis was approximately 20%; however, there was no report of lower inhibitor concentration use. DeKay et al. (1976) and Gnoni and Muci (1990) reported effects of avidin inhibition of FA synthesis in bovine mammary homogenate and eel-liver cytosol, respectively. DeKay et al. (1976) reported >90% inhibition of FA synthesis when their mammary preparation was preincubated with avidin before addition to the incubation medium. This preincubation approach differed from the approach used herein, and the resulting pattern of FA synthesized in their experiment shifted to a pattern dominated by butyric acid with the avidin preincubation treatment. Gnoni and Muci (1990) utilizing an avidin preincubation treatment reported results that are in agreement with others (DeKay et al., 1976). The avidin inhibition in the present system exhibited reduced sensitivity compared with the preincubation technique, but functioned similarly to the effects reported for avian ACC by Wakil et al. (1958).
Role of ACC in Milk Fat Synthesis
Our estimates of control coefficients indicate that ACC is not the rate-limiting step in de novo synthesis of FA in vitro. The term "rate-limiting" ascribed to ACC has been used for a long time and remains in use currently (Molenaar et al., 2003). A control coefficient less than 1.0 does not diminish the metabolic importance of ACC in the pathway for de novo FA synthesis, and a control coefficient of 0.63 represents a substantial degree of control over the complete pathway flux.
Davis et al. (2000) tested the effects of ACC overexpression in E. coli to examine the rate-controlling nature of this enzyme. There are differences between bacterial and mammalian ACC, but their findings represented the first direct approach to examining ACC control of FA synthesis in vivo. In their experiment, the potential for feedback from accumulating FA products was removed by incorporating a mutant thioesterase that directed overproduced FA into the culture medium, which served as a convenient metabolic sink. Overexpression resulted in an approximately 50-fold increase in ACC activity, and a 100-fold increase in intracellular malonyl-CoA concentration, but only a 6-fold increase in the rate of free FA synthesis, which indicated that subsequent pathway steps were exerting a degree of control over total pathway flux. Thus, ACC exerted strong effects on flux when activated (or inhibited), but, in the absence of complete control, limitations to the increases in flux anticipated from enzyme activity changes were apparent from the increased malonyl-CoA level.
Milk fat depression was associated with decreased activity of ACC and FAS in mammary tissue (Piperova et al., 2000). Similarly, milk fat depression induced by feeding a high concentrate/low forage diet was associated with significant reductions in mammary mRNA abundances for ACC, FAS, stearoyl-CoA desaturase, lipoprotein lipase, FA binding protein, fatty acyl CoA ligase, glycerol phosphate acyl transferase, and acyl-glycerol phosphate acyl transferase (Peterson et al., 2003). Biological regulation that causes a cell to reduce many enzymes in a metabolic pathway is likely an appropriate and efficient response for the cell to balance intermediate metabolite concentrations with reduced energy expenditure. It is a further indication that control is distributed over many of the components of metabolic pathways. Bauman and Griinari (2003) suggested further candidates that may provide control points in milk fat synthesis, namely peroxisome proliferator-activated receptors and sterol regulatory element binding proteins. Examining the transport of FA and substrates for de novo FA synthesis into mammary epithelial cells and components of the mechanism by which milk fat globules are secreted would likely reveal additional control points for FA synthesis.
| CONCLUSIONS |
|---|
|
|
|---|
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
Received for publication November 6, 2005. Accepted for publication March 1, 2006.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
Y. Zhan, N. Ginanni, M. R. Tota, M. Wu, N. W. Bays, V. M. Richon, N. E. Kohl, E. S. Bachman, P. R. Strack, and S. Krauss Control of Cell Growth and Survival by Enzymes of the Fatty Acid Synthesis Pathway in HCT-116 Colon Cancer Cells Clin. Cancer Res., September 15, 2008; 14(18): 5735 - 5742. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Liu, S. C. Degner, and D. F. Romagnolo Trans-10, Cis-12 Conjugated Linoleic Acid Inhibits Prolactin-Induced Cytosolic NADP+-Dependent Isocitrate Dehydrogenase Expression in Bovine Mammary Epithelial Cells J. Nutr., November 1, 2006; 136(11): 2743 - 2747. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |